GADOVIST

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Ireland, Japan, Lithuania, Malta, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug GADOVIST contains one active pharmaceutical ingredient (API):

1 Gadobutrol
UNII 1BJ477IO2L - GADOBUTROL

Gadobutrol is a gadolinium-based, hydrophilic, macrocyclic, electrically neutral contrast agent used in contrast-enhanced MRI (CE-MRI).

Read about Gadobutrol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
GADOVIST Solution for injection in prefilled syringe/cartridge Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
V08CA09 Gadobutrol V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 538902602151316, 538918120028803
Country: CA Health Products and Food Branch Identifier(s): 02241089
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29969-08-11
Country: EE Ravimiamet Identifier(s): 1133109, 1133110, 1345700, 1345711, 1359198, 1359200, 1380631, 1380642, 1380653, 1380664, 1380675, 1380686, 1380697, 1380709, 1380710, 1662645, 1662656, 1796485, 1796609, 1796610, 1796621, 1796665, 1800649, 1800650, 1800661, 1800672
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 63535, 63898
Country: FR Base de données publique des médicaments Identifier(s): 62143724, 62409751, 64755150, 67259654
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 121337, 234135, 386070, 386073, 90617, 90619, 90621
Country: HK Department of Health Drug Office Identifier(s): 51750, 57330
Country: JP 医薬品医療機器総合機構 Identifier(s): 7290416A1022, 7290416G1025, 7290416G2021, 7290416G3028
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1012552, 1012553, 1054116, 1054117, 1054118, 1054119, 1054120, 1054121, 1059675, 1059676, 1059677, 1059678, 1059679, 1059680, 1059682, 1059683, 1059684, 1059685, 1059686, 1059687, 1059688, 1059689, 1059690, 1059691, 1073494, 1073495, 1076612, 1076613, 1076614, 1076615, 1076845, 1077357, 1077358, 1078163, 1078164, 1078647, 1078648, 1078649, 1078650, 1078651, 1078652, 1078653, 1078654, 1078655, 1078656, 1078657, 1078658, 1078659, 1086397
Country: MT Medicines Authority Identifier(s): MA1354/00101, MA1354/00102
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 10704
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100104096
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64838001, W64838002, W64838003, W64838004, W64838005, W64838006, W64838007, W64839001, W64839002, W64839003
Country: SG Health Sciences Authority Identifier(s): 12399P, 13807P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699546772438, 8699546772445, 8699546773428, 8699546778638
Country: ZA Health Products Regulatory Authority Identifier(s): 34/28/0384, 34/28/0385, 34/28/0386, 34/28/0387

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.